Labcorp Expands MRD Testing for Breast, Lung, and Colon Cancer Recurrence Risk
LabCorp
Labcorp MRD tests now monitor recurrence risk across stage I–III breast cancer, stage I–IIIA non-small cell lung cancer and stage III colon cancer
Exome Sequencing
Integrated DNA Technologies Introduces New Hybridization Capture Solution to Accelerate Cancer Research
Integrated DNA Technologies
New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows
Sanger Sequencing for Specific and Small-Scale DNA Testing
Zahraa Chorghay, PhD
Cost, time, and labor considerations still make the Sanger method a better choice amidst new sequencing technologies
New Mayo Clinic Technology Helps Solve the Unsolvable in Rare Disease Diagnoses
Mayo Clinic
While manual reanalysis takes weeks, the new technology took from 10 seconds to 1.5 hours to reanalyze each unresolved case
Next Generation Sequencing Will Advance Newborn Screening
Madhuri Hegde, PhD, FACMG
Genome sequencing uncovered risks of several pediatric-onset conditions that may benefit from early intervention
Exome Sequencing Identifies Patients with HBOC Missed by Current Screening Guidelines
American Association for Cancer Research
Current guidelines ruled 60 percent of individuals identified with HBOC risk as ineligible for genetic testing
Save On Cost and Time Spent for Whole Exome Sequencing
QIAGEN
Download this infographic to learn about how you can perform whole exome sequencing (WES) at half the cost and in a third of the time
Personalizing Precision Medicine through Comprehensive Genomic Profiling
Erin Ayash, MS, LGC
To make personalized medicine the standard of care, we will need to go beyond sequencing tumor DNA
Solving Challenges in Exome Sequencing
QIAGEN
New solutions provide more coverage in a cost-effective way
Adopting NGS Technology for Routine Genetic Profiling
Thermo Fisher Scientific
Working through challenges in adoption to deliver a better standard of care